Showing results (211-220 of 1,338) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|September 2, 2024
A human embryonic stem cell-based model reveals the cell of origin of FOXR2-activated CNS neuroblastomaHitomi N Royston, Autumn B Hampton, Dhruv Bhagat, et al.Neuro-Oncology Advances|December 2, 2024
Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumorsMinu M Bhunia, Christopher M Stehn, Tyler A Jubenville, et al.Neuro-Oncology Advances|August 9, 2024
Predicting prognosis outcomes of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment using lipidomicsYi Zhong, Liying Zhou, Jingshen Xu, et al.Neuro-Oncology Advances|August 8, 2024
Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biologyMichael Griessmair, Claire Delbridge, Julian Ziegenfeuter, et al.Neuro-Oncology Advances|July 12, 2024
Neuro-oncology access in Sub-Saharan Africa: A literature review of challenges and opportunitiesW Elorm Yevudza, Vincent Buckman, Kwadwo Darko, et al.Neuro-Oncology Advances|July 18, 2024
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapyTuesday Haynes, Mark R Gilbert, Kevin Breen, et al.Neuro-Oncology Advances|July 18, 2024
NEO212, temozolomide conjugated to NEO100, exerts superior therapeutic activity over temozolomide in preclinical chemoradiation models of glioblastomaRadu O Minea, Thu Zan Thein, Zhuoyue Yang, et al.Neuro-Oncology Advances|August 19, 2024
Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastomaAhmed Gomaa, Yixing Huang, Amr Hagag, et al.Pageof 134